Parmax Pharma Ltd (BSE: 540359) is a Rajkot, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹0 Cr, it ranks #5,882 by market cap among the 6,197 Indian listed companies on FinBizNet, and #86 of 86 in Medicinal Chemicals and Botanical Products. At ₹135.00 (as of 16 Nov 2026), the share price is 2.9% below its 52-week high of ₹139.10 and 497.3% above its 52-week low of ₹22.60. The share price is up 309.1% over one year and up 16.9% over three months.
| Current Price | ₹135.00 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 540359 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| 52-Week Range | ₹22.60 – ₹139.10 |
| 1-Year Price Change | +309.1% |
| 3-Month Price Change | +16.9% |
| Beta (1Y) | 0.28 |
| Headquarters | Rajkot, Gujarat |
| Website | www.parmaxpharma.com |
Parmax Pharma Limited operates in the pharmaceutical business in India. It manufactures and sells bulk drugs, drug intermediates, and specialty chemicals. The company was incorporated in 1994 and is based in Rajkot, India.
1. 0-0
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Parmax Pharma Ltd | ₹0 Cr | — | — | — | +309.1% |
Listed by market capitalisation. Ratios are shown for context only.
Parmax Pharma Ltd is trading at ₹135.00, with a market capitalisation of ₹0 Cr.
Parmax Pharma Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Parmax Pharma Ltd is listed on the BSE under the scrip code 540359.
Parmax Pharma Ltd's share price is up 309.1% over one year and up 16.9% over three months. Its 52-week range is ₹22.60 to ₹139.10.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.